手机版 客户端

基于PTC病毒技术的高致病性禽流感病毒应急疫苗研究

基于PTC病毒技术的高致病性禽流感病毒应急疫苗研究
  • 导航:首页 > 科学基金
  • 批准号:81703414
  • 批准年度: 2017年
  • 学科分类:特种药物(H3006) |
  • 项目负责人:赵磊
  • 负责人职称:博士后
  • 依托单位:中国人民解放军军事医学科学院
  • 资助金额:20.1万元
  • 项目类别:青年科学基金项目
  • 研究期限:2018年01月01日 至 2020年12月31日
  • 中文关键词: PTC;病毒;高致病性禽流感;应急;疫苗
  • 英文关键词:Highly pathogenic avian influenza; PTC virus;biological warfare agent;vaccine

项目摘要

中文摘要

高致病性禽流感病毒(HPAIV)能够跨越种间隔离从禽类直接传染给人类,感染后致死率高。目前,HPAIV已表现出对一线抗流感药物的耐药趋势,且持续散发疫情导致人际传播风险不断加剧。同时,由于感染后死亡率高,HPAIV已被列为潜在生物战剂。基于PTC(提前终止密码子)病毒的新型疫苗研发策略为应急疫苗快速研发提供了新的思路。前期工作中,我们联合合作实验室基于H1N1流感病毒构建了PTC疫苗系统,在稳转正交翻译系统的细胞系中验证了其有效性及安全性,并对HPAIV H5和H7基因进行了全合成,为高致病性禽流感PTC病毒的构建奠定了基础。本项目基于前沿PTC病毒策略,探索HPAIV减毒疫苗的快速研发技术,最终希望获得安全高效的HPAIV PTC疫苗候选株。本研究的开展,将为高致病性禽流感应急疫苗的快速研发奠定基础,在流感频繁发生基因重配、抗原漂移的背景下,为我国高致病性禽流感疫情应急防控探索新的策略。

英文摘要

Highly pathogenic avian influenza virus (HPAIV) can spread across species isolated from poultry to human directly with high mortality, poses a serious threat to human health. The antiviral resistance of those virus to the main antiviral drugs had been detected recently and the continued sporadic human infection led to an increasing risk of interpersonal transmission,which exacerbated the possibility of avian influenza pandemic. At the same time, HPAIV has been classified as a potential biological warfare agent due to the high mortality rate after human infection. There is no effective strategy for rapid construction of emergency vaccines at present. Recently, a research on new type vaccine based on premature termination codon-harboring (PTC) virus was reported, which provides us a new strategy for rapid live-attenuated vaccine development of HPAIV. During the preliminary work, we jointly established the PTC virus system based on H1N1 virus with collaborating laboratory in Peking university, and verified its effectiveness and safety in the cell line with orthogonal translation system. The gene sequences encoding H5 and H7 subtype protein were synthesized completely, which given the basis to the construction of highly pathogenic avian influenza PTC virus. Based on the novel PTC virus strategy, this project explores the rapid development of HPAIV attenuated vaccine. We aim to obtain a safe and efficient HPAIV PTC vaccine candidate. This project will pave the way for the rapid development of highly pathogenic avian influenza emergency vaccine, and also explore the new strategy for epidemic prevention and control of highly pathogenic avian influenza with frequent reassortment and antigen drift in China.

评估说明

    国家自然科学基金项目“基于PTC病毒技术的高致病性禽流感病毒应急疫苗研究”发布于爱科学iikx,并永久归类于相关科学基金导航中,仅供广大科研工作者查询、学习、选题参考。国科金是根据国家发展科学技术的方针、政策和规划,以及科学技术发展方向,面向全国资助基础研究和应用研究,发挥着促进我国基础研究源头创新的作用。国科金的真正价值在于它能否为科学进步和社会发展带来积极的影响。

此文由 爱科学 编辑!:首页 > 科学基金 > 科学基金4 » 基于PTC病毒技术的高致病性禽流感病毒应急疫苗研究

推荐文章